Eli Lilly s blockbuster
diabetes drug Mounjaro and weight-loss therapy Zepbound, as well
as Novo Nordisk s rival medicines Ozempic and Wegovy
are being studied to see whether they can improve health.
Factbox - What other health conditions are weight loss drugs tested for? independantexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from independantexpress.com Daily Mail and Mail on Sunday newspapers.
Eli Lilly's blockbuster diabetes drug Mounjaro and weight-loss therapy Zepbound, as well Novo Nordisk's rival medicines Ozempic and Wegovy are being studied to see whether they can improve health in other ways. Lilly on Tuesday said Zepbound had been shown in a mid-stage trial to help reduce symptoms of a fatty liver disease. A study by the University of Copenhagen's Psychiatric Centre Rigshospitalet is investigating whether semaglutide, sold as Novo's Wegovy and Ozempic, can help reduce alcohol intake in 108 patients diagnosed with alcohol use disorder and obesity.
Novo Nordisk's blockbuster diabetes drug Ozempic and weight-loss therapy Wegovy are being studied to see whether they can improve health in other ways.
Novo Nordisk s blockbuster
diabetes drug Ozempic and weight-loss therapy Wegovy are being
studied to see whether they can improve health in other ways. Both treatments contain the active.